RxDoctor Payments Data

Felicia Sterman

Internal Medicine · San Francisco, CANPI 1124103353

Payments from drug & device makers

$774,546in general payments, 2019–2025

Across 745 payments — averaging $1039.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$705K
  • Janssen Products, LP$44K
  • Merck$22K
  • Viiv Healthcare Company$1K
  • Johnson & Johnson$597
  • Bausch Health US, LLC$299
  • plus $819 from 8 others

What the payments were for

  • Consulting fees$76,82226%
  • Speaking & faculty fees$138,29646%
  • Travel & lodging$72,07424%
  • Food & beverage$11,2174%
  • Education$670%

General payments by program year

19
20
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$774,546 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California

Other internal medicine in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →